SignalFDA/Bio

FDA APPROVES LANDMARK PANCREATIC CANCER DRUG THAT’S SHOWN TO IMPROVE SURVIVAL - AP NEWS - GNEWS

FDA approval plus survival improvement data drives high biotech impact.

What changed

FDA approval plus survival improvement data drives high biotech impact.

Why it matters

FDA approval plus survival improvement data drives high biotech impact. — impact context not separately stored; see What changed.

Sources